Skip to content
Open access

EVALUATION OF DAPANSUTRILE AGAINST PALMITATE-INDUCED NLRP3 INFLAMMASOME ACTIVATION AND INSULIN RESISTANCE IN 3T3-L1 ADIPOCYTES

Oct 2026 · Asian Journal of Pharmaceutical and Clinical Research · 0 citations

Abstract

Objective: Palmitate (PA)-induced lipid stress activates the NOD-, LRR-, and pyrin domain-containing protein 3 (NLRP3) inflammasome and disrupts insulin signaling in adipocytes. This study evaluated the protective effects of dapansutrile (DAPA) against PA-induced inflammasome activation and insulin resistance in differentiated 3T3-L1 adipocytes. Methods: Differentiated 3T3-L1 adipocytes were exposed to PA and treated with DAPA at 1, 5, or 10 μM. DAPA alone and MCC950 were included as treatment and pharmacological controls. Cell viability, insulin-stimulated 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl) amino)-2-deoxyglucose uptake, interleukin-1beta (IL-1β) secretion, oxidative stress, lipid handling, and adipokine release were assessed. Gene expression was examined using reverse transcription quantitative real-time polymerase chain reaction, while inflammasome-associated and insulin-signaling proteins were evaluated by Western blotting. Results: PA reduced cell viability and glucose uptake to 78.4% and 55.2% of control, respectively, and increased IL-1β secretion to 82.6 pg/mL (p<0.05). It increased the relative expression of Nlrp3, Pycard, Casp1, Il1b, and Il18, while reducing Irs1, Slc2a4, and Adipoq. DAPA produced concentration-dependent improvements in inflammatory, oxidative, and metabolic parameters. At 10 μM, viability and glucose uptake approached control values at 94.1% and 89.1%, respectively, while IL-1β declined to 30.8 pg/mL (p<0.05 vs. PA). Protein analysis indicated reduced inflammasome activation together with improved AKT and AS160 phosphorylation and membrane glucose transporter Type 4 expression. Conclusion: DAPA attenuated PA-induced inflammatory activation and improved insulin signaling in 3T3-L1 adipocytes, supporting further investigation of adipocyte NLRP3 inhibition in metabolic inflammation.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.